UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000047046 |
|---|---|
| Receipt number | R000053631 |
| Scientific Title | Postoperative complications of colorectal cancer and their impact on postoperative adjuvant chemotherapy and prognosis |
| Date of disclosure of the study information | 2022/03/01 |
| Last modified on | 2022/02/28 16:55:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Postoperative complications of colorectal cancer and their impact on postoperative adjuvant chemotherapy and prognosis
Acronym
Postoperative complications of colorectal cancer and their impact on postoperative adjuvant chemotherapy and prognosis
Scientific Title
Postoperative complications of colorectal cancer and their impact on postoperative adjuvant chemotherapy and prognosis
Scientific Title:Acronym
Postoperative complications of colorectal cancer and their impact on postoperative adjuvant chemotherapy and prognosis
Region
| Japan |
Condition
Condition
colon cancer
Classification by specialty
| Gastrointestinal surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Surgery and postoperative adjuvant chemotherapy are currently the standard treatments for resectable advanced colorectal cancer, but postoperative complications occur in 20-30% of patients after colorectal cancer surgery.
In our previous study, we reported that the occurrence of postoperative complications after colorectal cancer surgery is an important risk factor affecting the prognosis after colorectal cancer surgery using the case series of JFMC7/JFMC15/JFMC33.
However, we could not clarify the mechanism by which postoperative complications after colorectal cancer surgery affect the prognosis.
On the other hand, findings from other gastrointestinal cancers have reported that the occurrence of adverse events such as postoperative complications in gastrointestinal cancers can affect the implementation and continuation of adjuvant chemotherapy.
Therefore, in this study, we will investigate whether the occurrence of postoperative complications in colorectal cancer affects the continuation and implementation of adjuvant chemotherapy and, consequently, prognosis, using three studies, JFMC37/JFMC38/JFMC41, and discuss the clinical significance of postoperative complications in colorectal cancer.
Basic objectives2
Others
Basic objectives -Others
In this study, we will investigate whether the occurrence of postoperative complications in colorectal cancer affects the continuation and implementation of adjuvant chemotherapy and, consequently, prognosis, using three studies, JFMC37/JFMC38/JFMC41, and discuss the clinical significance of postoperative complications in colorectal cancer.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
overall survival
relapse-free survival
disease-free survival
Time-to-treatment-failure
Compliance
Relative Dose Intensity
Percentage of drug treatment discontinuation, dose reduction and drug suspension
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 21 | years-old | <= |
Age-upper limit
| 83 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
All registered patients of clinical studies (JFMC37 / JFMC38 / JFMC41) conducted by JFMC in the past
Key exclusion criteria
-
Target sample size
2297
Research contact person
Name of lead principal investigator
| 1st name | Takaki |
| Middle name | |
| Last name | Yoshikawa |
Organization
Japanese Foundation for Multidisciplinary Treatment of Cancer
Division name
Database Project Support Committee
Zip code
136-0071
Address
Tani Building 3F, 1-28-6 Kameido, Koto-ku, Tokyo
TEL
0356277594
jfmc-dc@jfmc.or.jp
Public contact
Name of contact person
| 1st name | Yukari/Masaru |
| Middle name | |
| Last name | Kawamura/Mutoh |
Organization
Japanese Foundation for Multidisciplinary Treatment of Cancer
Division name
Data Management Section/Statistical Analysis Section
Zip code
136-0071
Address
Tani Building 3F, 1-28-6 Kameido, Koto-ku, Tokyo
TEL
0356277594
Homepage URL
jfmc-dc@jfmc.or.jp
Sponsor or person
Institute
Japanese Foundation for Multidisciplinary Treatment of Cancer
Institute
Department
Personal name
Funding Source
Organization
Japanese Foundation for Multidisciplinary Treatment of Cancer
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Epidemiological and Clinical research Information Network (ECRIN)
Address
21-7 Shogoin Sannocho Sakyo-ku, Kyoto-shi, Kyoto-fu 606-8392
Tel
075-762-1200
naomi.iwahori@ecrin.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 03 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2022 | Year | 02 | Month | 17 | Day |
Date of IRB
| 2022 | Year | 02 | Month | 17 | Day |
Anticipated trial start date
| 2022 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2022 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
overall survival
relapse-free survival
disease-free survival
Time-to-treatment-failure
Compliance
Relative Dose Intensity
Percentage of drug treatment discontinuation, dose reduction and drug suspension
Management information
Registered date
| 2022 | Year | 03 | Month | 01 | Day |
Last modified on
| 2022 | Year | 02 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053631
